UniProtKB - P11474 (ERR1_HUMAN)
Steroid hormone receptor ERR1
ESRRA
Functioni
Sites
Feature key | Position(s) | DescriptionActions | Graphical view | Length |
---|---|---|---|---|
Sitei | 124 | Required for DNA-dependent dimerization | 1 |
Regions
Feature key | Position(s) | DescriptionActions | Graphical view | Length |
---|---|---|---|---|
DNA bindingi | 76 – 151 | Nuclear receptorPROSITE-ProRule annotationAdd BLAST | 76 | |
Zinc fingeri | 79 – 99 | NR C4-typePROSITE-ProRule annotationAdd BLAST | 21 | |
Zinc fingeri | 115 – 134 | NR C4-typePROSITE-ProRule annotationAdd BLAST | 20 |
GO - Molecular functioni
- DNA-binding transcription activator activity, RNA polymerase II-specific Source: Ensembl
- DNA-binding transcription factor activity Source: UniProtKB
- DNA-binding transcription factor activity, RNA polymerase II-specific Source: NTNU_SB
- DNA-binding transcription repressor activity, RNA polymerase II-specific Source: Ensembl
- nuclear receptor activity Source: GO_Central
- protein domain specific binding Source: UniProtKB
- RNA polymerase II cis-regulatory region sequence-specific DNA binding Source: GO_Central
- sequence-specific DNA binding Source: UniProtKB
- sequence-specific double-stranded DNA binding Source: ARUK-UCL
- steroid binding Source: InterPro
- steroid hormone receptor activity Source: InterPro
- zinc ion binding Source: InterPro
GO - Biological processi
- cartilage development Source: Ensembl
- mitochondrion organization Source: Reactome
- positive regulation of cellular response to insulin stimulus Source: Ensembl
- positive regulation of transcription by RNA polymerase II Source: BHF-UCL
- regulation of cell population proliferation Source: Ensembl
- regulation of ossification Source: Ensembl
- regulation of osteoblast differentiation Source: Ensembl
- regulation of osteoclast differentiation Source: Ensembl
- regulation of transcription, DNA-templated Source: UniProtKB
- regulation of transcription by RNA polymerase II Source: GO_Central
- response to estradiol Source: Ensembl
- transcription initiation from RNA polymerase II promoter Source: Reactome
Keywordsi
Molecular function | DNA-binding, Receptor |
Biological process | Transcription, Transcription regulation |
Ligand | Metal-binding, Zinc |
Enzyme and pathway databases
PathwayCommonsi | P11474 |
Reactomei | R-HSA-1989781, PPARA activates gene expression R-HSA-2151201, Transcriptional activation of mitochondrial biogenesis R-HSA-383280, Nuclear Receptor transcription pathway R-HSA-8939902, Regulation of RUNX2 expression and activity |
SignaLinki | P11474 |
SIGNORi | P11474 |
Names & Taxonomyi
Protein namesi | Recommended name: Steroid hormone receptor ERR1Alternative name(s): Estrogen receptor-like 1 Estrogen-related receptor alpha Short name: ERR-alpha Nuclear receptor subfamily 3 group B member 1 |
Gene namesi | Name:ESRRA Synonyms:ERR1, ESRL1, NR3B1 |
Organismi | Homo sapiens (Human) |
Taxonomic identifieri | 9606 [NCBI] |
Taxonomic lineagei | Eukaryota › Metazoa › Chordata › Craniata › Vertebrata › Euteleostomi › Mammalia › Eutheria › Euarchontoglires › Primates › Haplorrhini › Catarrhini › Hominidae › Homo |
Proteomesi |
|
Organism-specific databases
HGNCi | HGNC:3471, ESRRA |
MIMi | 601998, gene |
neXtProti | NX_P11474 |
VEuPathDBi | HostDB:ENSG00000173153.13 |
Subcellular locationi
Cytoskeleton
- microtubule cytoskeleton Source: HPA
Extracellular region or secreted
- intercellular bridge Source: HPA
Nucleus
- fibrillar center Source: HPA
- nuclear chromatin Source: NTNU_SB
- nucleoplasm Source: HPA
- nucleus Source: UniProtKB
Other locations
- cytoplasm Source: UniProtKB
Keywords - Cellular componenti
Cytoplasm, NucleusPathology & Biotechi
Mutagenesis
Feature key | Position(s) | DescriptionActions | Graphical view | Length |
---|---|---|---|---|
Mutagenesisi | 14 | K → R: Some loss of sumoylation. Complete loss of sumoylation; when associated with R-403. 2 Publications | 1 | |
Mutagenesisi | 19 | S → A: 50% loss of phosphorylation but represses transactivation activity in the absence of coactivator. Almost complete loss of phosphorylation and 2-fold loss of repression of transactivation activity in response to coactivator; when associated with A-22. 2 Publications | 1 | |
Mutagenesisi | 19 | S → D: Represses transactivation activity in response to coactivator as for wild type; when associated with D-22. 2 Publications | 1 | |
Mutagenesisi | 22 | S → A: 15% loss of phosphorylation but little transactivating activity. Almost complete loss of phosphorylation and 2-fold loss of repression of transactivation activity in the presence of coactivator; when associated with A-19. 2 Publications | 1 | |
Mutagenesisi | 22 | S → D: Represses transactivation activity in response to coactivator as for wild type; when associated with D-19. 2 Publications | 1 | |
Mutagenesisi | 118 | S → A: Binds DNA as a monomer or as a dimer as for wild type. No effect on interaction with PPARGC1A. 1 Publication | 1 | |
Mutagenesisi | 124 | T → A: Binds DNA predominantly as a monomer. Loss of interaction with PPARGC1A. 1 Publication | 1 | |
Mutagenesisi | 129 | K → R: Abolishes acetylation by PCAF/KAT2B; when associated with R-138, R-160 and R-162. 1 Publication | 1 | |
Mutagenesisi | 138 | K → R: Abolishes acetylation by PCAF/KAT2B; when associated with R-129, R-160 and R-162. 1 Publication | 1 | |
Mutagenesisi | 160 | K → R: Abolishes acetylation by PCAF/KAT2B; when associated with R-129, R-138 and R-162. 1 Publication | 1 | |
Mutagenesisi | 162 | K → R: Abolishes acetylation by PCAF/KAT2B; when associated with R-129, R-138 and R-160. 1 Publication | 1 | |
Mutagenesisi | 258 – 262 | MSVLQ → VSVLE: Almost complete loss of interaction to L2 or to L3 of PPARGC1A. 1 Publication | 5 | |
Mutagenesisi | 259 | S → H: Little effect on binding L2 of PPARGC1A. Greatly reduced binding to L3 of PPARGC1A. 1 Publication | 1 | |
Mutagenesisi | 315 | R → A: Almost complete loss of interaction to L2 or to L3 of PPARGC1A. 1 Publication | 1 | |
Mutagenesisi | 338 | D → A: Almost complete loss of interaction to L2 or to L3 of PPARGC1A. 1 Publication | 1 | |
Mutagenesisi | 341 | H → A: Little effect on binding L3 of PPARGC1A. 1 Publication | 1 | |
Mutagenesisi | 343 | E → A: No effect on binding L3 of PPARGC1A. 1 Publication | 1 | |
Mutagenesisi | 403 | K → R: Decrease in sumoylation. No effect on transcriptional activity. Complete loss of sumoylation; when associated with R-14. 2 Publications | 1 | |
Mutagenesisi | 413 | L → A: Loss of coactivation activity; when associated with A-418. Loss of increased response to coactivator; when associated with A-19 and A-418. 1 Publication | 1 | |
Mutagenesisi | 418 | L → A: Loss of coactivation activity; when associated with A-413. Loss of increased response to coactivator activity; when associated with A-19 and A-413. 1 Publication | 1 | |
Mutagenesisi | 421 – 423 | Missing : Greatly reduced interaction with L3 motif of PPARGC1A. Less effect on binding to L2 motif of PPARGC1A. 1 Publication | 3 | |
Mutagenesisi | 423 | D → A: Little effect on binding L3 of PPARGC1A. | 1 |
Organism-specific databases
DisGeNETi | 2101 |
OpenTargetsi | ENSG00000173153 |
PharmGKBi | PA27887 |
Miscellaneous databases
Pharosi | P11474, Tchem |
Chemistry databases
ChEMBLi | CHEMBL3429 |
DrugBanki | DB06833, 1-CYCLOHEXYL-N-{[1-(4-METHYLPHENYL)-1H-INDOL-3-YL]METHYL}METHANAMINE DB04468, Afimoxifene DB06732, beta-Naphthoflavone DB00255, Diethylstilbestrol DB07776, Flavone DB01645, Genistein DB00197, Troglitazone |
DrugCentrali | P11474 |
GuidetoPHARMACOLOGYi | 622 |
Genetic variation databases
BioMutai | ESRRA |
DMDMi | 215274146 |
PTM / Processingi
Molecule processing
Feature key | Position(s) | DescriptionActions | Graphical view | Length |
---|---|---|---|---|
ChainiPRO_0000053660 | 1 – 423 | Steroid hormone receptor ERR1Add BLAST | 423 |
Amino acid modifications
Feature key | Position(s) | DescriptionActions | Graphical view | Length |
---|---|---|---|---|
Cross-linki | 14 | Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO)2 Publications | ||
Modified residuei | 19 | PhosphoserineCombined sources2 Publications | 1 | |
Modified residuei | 22 | PhosphoserineCombined sources2 Publications | 1 | |
Modified residuei | 129 | N6-acetyllysine; by PCAF/KAT2B1 Publication | 1 | |
Modified residuei | 138 | N6-acetyllysine; by PCAF/KAT2B1 Publication | 1 | |
Modified residuei | 160 | N6-acetyllysine; by PCAF/KAT2B1 Publication | 1 | |
Modified residuei | 162 | N6-acetyllysine; by PCAF/KAT2B1 Publication | 1 | |
Cross-linki | 189 | Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2)Combined sources | ||
Cross-linki | 403 | Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO); alternate2 Publications | ||
Cross-linki | 403 | Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2); alternateCombined sources |
Post-translational modificationi
Keywords - PTMi
Acetylation, Isopeptide bond, Phosphoprotein, Ubl conjugationProteomic databases
EPDi | P11474 |
jPOSTi | P11474 |
MassIVEi | P11474 |
PaxDbi | P11474 |
PeptideAtlasi | P11474 |
PRIDEi | P11474 |
ProteomicsDBi | 52781 [P11474-1] 52782 [P11474-2] |
PTM databases
iPTMneti | P11474 |
PhosphoSitePlusi | P11474 |
Expressioni
Inductioni
Gene expression databases
Bgeei | ENSG00000173153, Expressed in apex of heart and 218 other tissues |
ExpressionAtlasi | P11474, baseline and differential |
Genevisiblei | P11474, HS |
Organism-specific databases
HPAi | ENSG00000173153, Tissue enhanced (skeletal) |
Interactioni
Subunit structurei
Binds DNA as a monomer or a homodimer.
Interacts (via the AF2 domain) with coactivator PPARGC1A (via the L3 motif); the interaction greatly enhances transcriptional activity of genes involved in energy metabolism.
Interacts with PIAS4; the interaction enhances sumoylation.
Interacts with MAPK15; promotes re-localization of ESRRA to the cytoplasm through a XPO1-dependent mechanism then inhibits ESRRA transcriptional activity.
5 PublicationsBinary interactionsi
Hide detailsP11474
GO - Molecular functioni
- protein domain specific binding Source: UniProtKB
Protein-protein interaction databases
BioGRIDi | 108405, 50 interactors |
DIPi | DIP-35053N |
IntActi | P11474, 30 interactors |
MINTi | P11474 |
STRINGi | 9606.ENSP00000384851 |
Chemistry databases
BindingDBi | P11474 |
Miscellaneous databases
RNActi | P11474, protein |
Structurei
Secondary structure
3D structure databases
SMRi | P11474 |
ModBasei | Search... |
PDBe-KBi | Search... |
Miscellaneous databases
EvolutionaryTracei | P11474 |
Family & Domainsi
Domains and Repeats
Feature key | Position(s) | DescriptionActions | Graphical view | Length |
---|---|---|---|---|
Domaini | 193 – 421 | NR LBDPROSITE-ProRule annotationAdd BLAST | 229 |
Region
Feature key | Position(s) | DescriptionActions | Graphical view | Length |
---|---|---|---|---|
Regioni | 1 – 76 | Repressor domainAdd BLAST | 76 | |
Regioni | 403 – 423 | AF-2 domainAdd BLAST | 21 |
Sequence similaritiesi
Zinc finger
Feature key | Position(s) | DescriptionActions | Graphical view | Length |
---|---|---|---|---|
Zinc fingeri | 79 – 99 | NR C4-typePROSITE-ProRule annotationAdd BLAST | 21 | |
Zinc fingeri | 115 – 134 | NR C4-typePROSITE-ProRule annotationAdd BLAST | 20 |
Keywords - Domaini
Zinc-fingerPhylogenomic databases
eggNOGi | KOG3575, Eukaryota |
GeneTreei | ENSGT00940000160341 |
HOGENOMi | CLU_007368_11_0_1 |
InParanoidi | P11474 |
OMAi | KRPRCPF |
OrthoDBi | 1390068at2759 |
PhylomeDBi | P11474 |
TreeFami | TF323751 |
Family and domain databases
Gene3Di | 1.10.565.10, 1 hit 3.30.50.10, 1 hit |
IDEALi | IID00021 |
InterProi | View protein in InterPro IPR035500, NHR-like_dom_sf IPR000536, Nucl_hrmn_rcpt_lig-bd IPR001723, Nuclear_hrmn_rcpt IPR027289, Oest-rel_rcp IPR024178, Oest_rcpt/oest-rel_rcp IPR001628, Znf_hrmn_rcpt IPR013088, Znf_NHR/GATA |
Pfami | View protein in Pfam PF00104, Hormone_recep, 1 hit PF00105, zf-C4, 1 hit |
PIRSFi | PIRSF002527, ER-like_NR, 1 hit PIRSF500939, ERR1-2-3, 1 hit |
PRINTSi | PR00398, STRDHORMONER PR00047, STROIDFINGER |
SMARTi | View protein in SMART SM00430, HOLI, 1 hit SM00399, ZnF_C4, 1 hit |
SUPFAMi | SSF48508, SSF48508, 1 hit |
PROSITEi | View protein in PROSITE PS51843, NR_LBD, 1 hit PS00031, NUCLEAR_REC_DBD_1, 1 hit PS51030, NUCLEAR_REC_DBD_2, 1 hit |
s (2+)i Sequence
Sequence statusi: Complete.
This entry describes 2 produced by isoformsialternative splicing. AlignAdd to basketThis entry has 2 described isoforms and 4 potential isoforms that are computationally mapped.Show allAlign All
This isoform has been chosen as the sequence. All positional information in this entry refers to it. This is also the sequence that appears in the downloadable versions of the entry. canonicali
10 20 30 40 50
MSSQVVGIEP LYIKAEPASP DSPKGSSETE TEPPVALAPG PAPTRCLPGH
60 70 80 90 100
KEEEDGEGAG PGEQGGGKLV LSSLPKRLCL VCGDVASGYH YGVASCEACK
110 120 130 140 150
AFFKRTIQGS IEYSCPASNE CEITKRRRKA CQACRFTKCL RVGMLKEGVR
160 170 180 190 200
LDRVRGGRQK YKRRPEVDPL PFPGPFPAGP LAVAGGPRKT AAPVNALVSH
210 220 230 240 250
LLVVEPEKLY AMPDPAGPDG HLPAVATLCD LFDREIVVTI SWAKSIPGFS
260 270 280 290 300
SLSLSDQMSV LQSVWMEVLV LGVAQRSLPL QDELAFAEDL VLDEEGARAA
310 320 330 340 350
GLGELGAALL QLVRRLQALR LEREEYVLLK ALALANSDSV HIEDAEAVEQ
360 370 380 390 400
LREALHEALL EYEAGRAGPG GGAERRRAGR LLLTLPLLRQ TAGKVLAHFY
410 420
GVKLEGKVPM HKLFLEMLEA MMD
Computationally mapped potential isoform sequencesi
There are 4 potential isoforms mapped to this entry.BLASTAlignShow allAdd to basketF5GWT5 | F5GWT5_HUMAN | Steroid hormone receptor ERR1 | ESRRA | 109 | Annotation score: | ||
A0A6E1WCP9 | A0A6E1WCP9_HUMAN | Steroid hormone receptor ERR1 | ESRRA | 506 | Annotation score: | ||
H0YGT3 | H0YGT3_HUMAN | Steroid hormone receptor ERR1 | ESRRA | 198 | Annotation score: | ||
F5H0E9 | F5H0E9_HUMAN | Steroid hormone receptor ERR1 | ESRRA | 162 | Annotation score: |
Sequence cautioni
Alternative sequence
Feature key | Position(s) | DescriptionActions | Graphical view | Length |
---|---|---|---|---|
Alternative sequenceiVSP_035756 | 191 | Missing in isoform 2. 1 Publication | 1 |
Sequence databases
Select the link destinations: EMBLi GenBanki DDBJi Links Updated | X51416 mRNA Translation: CAA35778.1 Frameshift. L38487 mRNA Translation: AAB17015.1 Different initiation. AP001453 Genomic DNA No translation available. |
CCDSi | CCDS41667.1 [P11474-1] CCDS60830.1 [P11474-2] |
PIRi | A29345 |
RefSeqi | NP_001269379.1, NM_001282450.1 [P11474-1] NP_001269380.1, NM_001282451.1 [P11474-2] NP_004442.3, NM_004451.4 [P11474-1] |
Genome annotation databases
Ensembli | ENST00000000442; ENSP00000000442; ENSG00000173153 [P11474-1] ENST00000405666; ENSP00000384851; ENSG00000173153 [P11474-1] |
GeneIDi | 2101 |
KEGGi | hsa:2101 |
UCSCi | uc001nzr.3, human [P11474-1] |
Keywords - Coding sequence diversityi
Alternative splicingSimilar proteinsi
Cross-referencesi
Web resourcesi
Atlas of Genetics and Cytogenetics in Oncology and Haematology |
Sequence databases
Select the link destinations: EMBLi GenBanki DDBJi Links Updated | X51416 mRNA Translation: CAA35778.1 Frameshift. L38487 mRNA Translation: AAB17015.1 Different initiation. AP001453 Genomic DNA No translation available. |
CCDSi | CCDS41667.1 [P11474-1] CCDS60830.1 [P11474-2] |
PIRi | A29345 |
RefSeqi | NP_001269379.1, NM_001282450.1 [P11474-1] NP_001269380.1, NM_001282451.1 [P11474-2] NP_004442.3, NM_004451.4 [P11474-1] |
3D structure databases
Select the link destinations: PDBei RCSB PDBi PDBji Links Updated | PDB entry | Method | Resolution (Å) | Chain | Positions | PDBsum |
1XB7 | X-ray | 2.50 | A | 194-423 | [»] | |
2PJL | X-ray | 2.30 | A/B | 193-423 | [»] | |
3D24 | X-ray | 2.11 | A/C | 192-423 | [»] | |
3K6P | X-ray | 2.00 | A | 193-423 | [»] | |
SMRi | P11474 | |||||
ModBasei | Search... | |||||
PDBe-KBi | Search... |
Protein-protein interaction databases
BioGRIDi | 108405, 50 interactors |
DIPi | DIP-35053N |
IntActi | P11474, 30 interactors |
MINTi | P11474 |
STRINGi | 9606.ENSP00000384851 |
Chemistry databases
BindingDBi | P11474 |
ChEMBLi | CHEMBL3429 |
DrugBanki | DB06833, 1-CYCLOHEXYL-N-{[1-(4-METHYLPHENYL)-1H-INDOL-3-YL]METHYL}METHANAMINE DB04468, Afimoxifene DB06732, beta-Naphthoflavone DB00255, Diethylstilbestrol DB07776, Flavone DB01645, Genistein DB00197, Troglitazone |
DrugCentrali | P11474 |
GuidetoPHARMACOLOGYi | 622 |
PTM databases
iPTMneti | P11474 |
PhosphoSitePlusi | P11474 |
Genetic variation databases
BioMutai | ESRRA |
DMDMi | 215274146 |
Proteomic databases
EPDi | P11474 |
jPOSTi | P11474 |
MassIVEi | P11474 |
PaxDbi | P11474 |
PeptideAtlasi | P11474 |
PRIDEi | P11474 |
ProteomicsDBi | 52781 [P11474-1] 52782 [P11474-2] |
Protocols and materials databases
ABCDi | P11474, 6 sequenced antibodies |
Antibodypediai | 7260, 542 antibodies |
DNASUi | 2101 |
Genome annotation databases
Ensembli | ENST00000000442; ENSP00000000442; ENSG00000173153 [P11474-1] ENST00000405666; ENSP00000384851; ENSG00000173153 [P11474-1] |
GeneIDi | 2101 |
KEGGi | hsa:2101 |
UCSCi | uc001nzr.3, human [P11474-1] |
Organism-specific databases
CTDi | 2101 |
DisGeNETi | 2101 |
GeneCardsi | ESRRA |
HGNCi | HGNC:3471, ESRRA |
HPAi | ENSG00000173153, Tissue enhanced (skeletal) |
MIMi | 601998, gene |
neXtProti | NX_P11474 |
OpenTargetsi | ENSG00000173153 |
PharmGKBi | PA27887 |
VEuPathDBi | HostDB:ENSG00000173153.13 |
GenAtlasi | Search... |
Phylogenomic databases
eggNOGi | KOG3575, Eukaryota |
GeneTreei | ENSGT00940000160341 |
HOGENOMi | CLU_007368_11_0_1 |
InParanoidi | P11474 |
OMAi | KRPRCPF |
OrthoDBi | 1390068at2759 |
PhylomeDBi | P11474 |
TreeFami | TF323751 |
Enzyme and pathway databases
PathwayCommonsi | P11474 |
Reactomei | R-HSA-1989781, PPARA activates gene expression R-HSA-2151201, Transcriptional activation of mitochondrial biogenesis R-HSA-383280, Nuclear Receptor transcription pathway R-HSA-8939902, Regulation of RUNX2 expression and activity |
SignaLinki | P11474 |
SIGNORi | P11474 |
Miscellaneous databases
BioGRID-ORCSi | 2101, 50 hits in 897 CRISPR screens |
ChiTaRSi | ESRRA, human |
EvolutionaryTracei | P11474 |
GeneWikii | Estrogen-related_receptor_alpha |
GenomeRNAii | 2101 |
Pharosi | P11474, Tchem |
PROi | PR:P11474 |
RNActi | P11474, protein |
SOURCEi | Search... |
Gene expression databases
Bgeei | ENSG00000173153, Expressed in apex of heart and 218 other tissues |
ExpressionAtlasi | P11474, baseline and differential |
Genevisiblei | P11474, HS |
Family and domain databases
Gene3Di | 1.10.565.10, 1 hit 3.30.50.10, 1 hit |
IDEALi | IID00021 |
InterProi | View protein in InterPro IPR035500, NHR-like_dom_sf IPR000536, Nucl_hrmn_rcpt_lig-bd IPR001723, Nuclear_hrmn_rcpt IPR027289, Oest-rel_rcp IPR024178, Oest_rcpt/oest-rel_rcp IPR001628, Znf_hrmn_rcpt IPR013088, Znf_NHR/GATA |
Pfami | View protein in Pfam PF00104, Hormone_recep, 1 hit PF00105, zf-C4, 1 hit |
PIRSFi | PIRSF002527, ER-like_NR, 1 hit PIRSF500939, ERR1-2-3, 1 hit |
PRINTSi | PR00398, STRDHORMONER PR00047, STROIDFINGER |
SMARTi | View protein in SMART SM00430, HOLI, 1 hit SM00399, ZnF_C4, 1 hit |
SUPFAMi | SSF48508, SSF48508, 1 hit |
PROSITEi | View protein in PROSITE PS51843, NR_LBD, 1 hit PS00031, NUCLEAR_REC_DBD_1, 1 hit PS51030, NUCLEAR_REC_DBD_2, 1 hit |
ProtoNeti | Search... |
MobiDBi | Search... |
Entry informationi
Entry namei | ERR1_HUMAN | |
Accessioni | P11474Primary (citable) accession number: P11474 Secondary accession number(s): Q14514 | |
Entry historyi | Integrated into UniProtKB/Swiss-Prot: | October 1, 1989 |
Last sequence update: | November 25, 2008 | |
Last modified: | February 10, 2021 | |
This is version 225 of the entry and version 3 of the sequence. See complete history. | ||
Entry statusi | Reviewed (UniProtKB/Swiss-Prot) | |
Annotation program | Chordata Protein Annotation Program | |
Disclaimer | Any medical or genetic information present in this entry is provided for research, educational and informational purposes only. It is not in any way intended to be used as a substitute for professional medical advice, diagnosis, treatment or care. |
Miscellaneousi
Keywords - Technical termi
3D-structure, Direct protein sequencing, Reference proteomeDocuments
- Human chromosome 11
Human chromosome 11: entries, gene names and cross-references to MIM - MIM cross-references
Online Mendelian Inheritance in Man (MIM) cross-references in UniProtKB/Swiss-Prot - PDB cross-references
Index of Protein Data Bank (PDB) cross-references - SIMILARITY comments
Index of protein domains and families